SuperworthCorvus Pharmaceuticals shares outstanding CRVS
Diluted shares outstanding, averaged over each quarter, from 2015.
- Latest quarter, to Jun 30, 2026
- 92.4M
- On a year earlier
- +18.8%
- more shares
Corvus Pharmaceuticals had 92.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 18.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 83M | +21% |
| FY2024 | 68.3M | +39% |
| FY2023 | 49M | +5% |
| FY2022 | 46.6M | +0% |
| FY2021 | 46.6M | +57% |
| FY2020 | 29.7M | +1% |
| FY2019 | 29.4M | +0% |
| FY2018 | 29.3M | +42% |
| FY2017 | 20.7M | +2% |
| FY2016 | 20.3M | +4364% |
| FY2015 | 453.8K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 92.4M | +19% | |
| Q1 FY26 | 90M | +20% | |
| Q4 FY25 | 83M | +21% | |
| Q3 FY25 | 82.8M | +24% | |
| Q2 FY25 | 77.8M | +30% | |
| Q1 FY25 | 75.2M | +53% | |
| Q4 FY24 | 68.3M | +39% | |
| Q3 FY24 | 66.7M | +36% | |
| Q2 FY24 | 59.7M | +26% | |
| Q1 FY24 | 49M | +5% | |
| Q4 FY23 | 49M | +5% | |
| Q3 FY23 | 49M | +5% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Corvus Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.